TELA Bio Analyst Price Targets - Benzinga

TELA Bio Inc

TELANASDAQ

Trade with Public

Trade with Public

$0.9750

-0.035-3.47%

最終更新: Oct 16, 4:27 PM

$0.9750

-0.035-3.47%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

TELA Bio Analyst Price Targets

Wall Street analyst price targets and consensus rating for TELA Bio (TELA).

Price Target Range — 9 Quarters

Analyst Consensus — 7 Analysts

3S.Buy

3Buy

1Hold

Consensus RatingBuy# Analysts7Avg. Consensus PT$5Upside to Avg. PT+361.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 25, 2026	Craig-Hallum	Chase Knickerbocker	Initiate	Buy	$2
Mar 27, 2026	Citizens	David Turkaly	PT Cut	Market Outperform	$5→$3
Mar 25, 2026	Piper Sandler	Matt O'Brien	PT Cut	Neutral	$1→$1
Mar 25, 2026	Lake Street	Frank Takkinen	PT Cut	Buy	$3→$2
Mar 25, 2026	Canaccord Genuity	Caitlin Roberts	PT Cut	Buy	$4→$2
Dec 1, 2025	Lake Street	Frank Takkinen	PT Cut	Buy	$6→$3
Nov 18, 2025	Canaccord Genuity	Caitlin Roberts	PT Cut	Buy	$7→$4
Nov 14, 2025	Piper Sandler	Matt O'Brien	PT Cut	Neutral	$2→$1
Nov 14, 2025	Citizens	David Turkaly	PT Cut	Market Outperform	$7→$5
Mar 21, 2025	Canaccord Genuity	Caitlin Cronin	PT Cut	Buy	$12→$7
Mar 21, 2025	Citizens Capital Markets	David Turkaly	PT Cut	Market Outperform	$12→$7
Mar 21, 2025	Piper Sandler	Matt O'Brien	Downgrade	Overweight→Neutral	$5→$2
Nov 8, 2024	Piper Sandler	Matt O'Brien	PT Cut	Overweight	$8→$5
Oct 4, 2024	Canaccord Genuity	Caitlin Cronin	Maintained	Buy	$12
Aug 13, 2024	JMP Securities	David Turkaly	PT Cut	Market Outperform	$15→$12
Aug 13, 2024	Lake Street	Frank Takkinen	PT Cut	Buy	$14→$8
Aug 13, 2024	Piper Sandler	Matt O'Brien	PT Cut	Overweight	$10→$8
Aug 13, 2024	Canaccord Genuity	Caitlin Cronin	PT Cut	Buy	$14→$12
Jul 25, 2024	Canaccord Genuity	Caitlin Cronin	Maintained	Buy	$14
May 10, 2024	Piper Sandler	Matt O'Brien	PT Cut	Overweight	$12→$10

More with Benzinga EdgeGet Access

Analyst Ratings News

5 Stock Picks Last Week From Wall Street's Most Accurate Analysts

U.S. stocks rose as oil fell on Strait of Hormuz hopes; Benzinga highlights top analysts’ picks: OKTA, AKAM and TELA.

Avi Kapoor

PRO
Craig-Hallum Initiates Coverage On TELA Bio with Buy Rating, Announces Price Target of $2

Craig-Hallum analyst Chase Knickerbocker initiates coverage on TELA Bio (NASDAQ:TELA) with a Buy rating and announces Price Target of $2.

Benzinga Newsdesk

PRO
Citizens Maintains Market Outperform on TELA Bio, Lowers Price Target to $3

Citizens analyst David Turkaly maintains TELA Bio (NASDAQ:TELA) with a Market Outperform and lowers the price target from $5 to $3.

Benzinga Newsdesk

TELA Bio Analysts Cut Their Forecasts After Q4 Results

TELA Bio (NASDAQ:TELA) reported mixed Q4 results, with higher losses but lower sales than expected. Analysts lowered price targets for the stock.

Avi Kapoor

Amazon To Rally Around 49%? Here Are 10 Top Analyst Forecasts For Wednesday

Top analysts change outlook for top names. Citigroup, Tigress Fin, Piper Sandler, Morgan Stanley, HC Wainwright, Susquehanna, Raymond James and Goldman Sachs adjust price targets for companies like Braze, Amazon, TELA Bio, Smithfield Foods, Corcept Therapeutics, TechnipFMC, Phillips 66, and KB Home. See all changes at benzinga.com/analyst-stock-ratings.

Avi Kapoor

PRO
Piper Sandler Maintains Neutral on TELA Bio, Lowers Price Target to $1

Piper Sandler analyst Matt O'Brien maintains TELA Bio (NASDAQ:TELA) with a Neutral and lowers the price target from $1.25 to $1.

Benzinga Newsdesk